Villere Balanced Inv holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Villere Balanced Fund Investor Class VILLX
- NAV / 1-Day Return 17.71 / 0.00
- Total Assets 62.7M
-
Adj. Expense Ratio
0.800%
- Expense Ratio 0.900%
- Distribution Fee Level Above Average
- Share Class Type No Load
- Category Moderately Aggressive Allocation
- Investment Style Mid Value
- Credit Quality / Interest Rate Sensitivity —
- Status Limited
- TTM Yield 1.29%
- Turnover 11%
USD | NAV as of Jun 13, 2026 | 1-Day Return as of Jun 13, 2026, 1:23 AM GMT+0
Morningstar’s Analysis VILLX
Will VILLX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the VILLX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of VILLX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 28.4
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Invesco Shrt-Trm Inv Gov&Agcy Instl | 8.19 | 7M | Cash and Equivalents |
Visa Inc Class A | 3.88 | 3M | Financial Services |
Pool Corp | 3.41 | 3M | Industrials |
Amazon.com Inc | 3.33 | 3M | Consumer Cyclical |
JPMorgan Chase & Co | 2.73 | 2M | Financial Services |
Palomar Holdings Inc | 2.55 | 2M | Financial Services |
Ligand Pharmaceuticals Inc | 2.52 | 2M | Healthcare |
Tidewater Inc | 2.51 | 2M | Energy |
Stryker Corp | 2.51 | 2M | Healthcare |
Johnson & Johnson | 2.50 | 2M | Healthcare |
United States